Some Diabetes Medications Found To Cause Flesh Eating Infection
Medications used to treat diabetic patients are being recalled by the FDA for causing a deadly and rare flesh-eating condition.
The medications, sodium-glucose cotransporter-2 (SGLT2) inhibitors, are used to treat those who suffer from type-2 diabetes. The FDA released a statement about the medications which warned users of the potential issue. Invokana, Farxiga, and Jardiance are three of the more popular brands associated with the condition.
The flesh-eating infection is called “necrotizing fasciitis of the perineum” and it focuses on the genital area of the body. It is sometimes referred to as “Fournier’s gangrene.” The infection, though mostly rare, is limited to the genital area and carries a death rate of 20% or more. The flesh-eating bacteria has been found in 12 cases by an FDA report ran over a five year period between 2013 and 2018. There were six cases prior over a period of 30 years linked to diabetic medications.
The sharp rise associated with new diabetic medications has prompted the FDA to issue the abrupt warning.
Of the 12 modern cases, all persons with the infection were subjected to surgery, often leaving the person disfigured. One person died.
The FDA warning advises those taking any of the listed medication brands to contact their physician if they experience “tenderness, redness, or swelling of the genitals or the area from the genitals back to the rectum and have a fever above 100.4 F or a general feeling of being unwell.”
SGLT2 inhibitors were approved by the FDA in 2013. They are supposed to lower blood sugar in diabetics.
Author: Jim Satney
PrepForThat’s Editor and lead writer for political, survival, and weather categories.
*As an Amazon Associate I earn from qualifying purchases
Like Us On Facebook -